| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Salvianolic Acid | Alcoholic Liver Disease | 1 | PM | 29729281 | 📋 | Salvianolic acid A alleviates chronic ethanol-induced liver injury via promotion of β-catenin nuclear accumulation by restoring SIRT1 in rats |
| Salvianolic Acid | Hepatic Fibrosis | 11 | PM | 38184998 | 📋 | Salvianolic acid B attenuates liver fibrosis by targeting Ecm1 and inhibiting hepatocyte ferroptosis |
| Salvianolic Acid | Hepatic Fibrosis | 10 | PM | 37749921 | 📋 | Pharmacodynamic study of chitosan in combination with salvianolic acid B in the treatment of CC14 -induced liver fibrosis in mice |
| Salvianolic Acid | Hepatic Fibrosis | 9 | PM | 37451016 | 📋 | Salvianolic acid B inhibits hepatic stellate cell activation and liver fibrosis by targeting PDGFRβ |
| Salvianolic Acid | Hepatic Fibrosis | 8 | PM | 36627345 | 📋 | Salvianolic acid B suppresses hepatic fibrosis by inhibiting ceramide glucosyltransferase in hepatic stellate cells |
| Salvianolic Acid | Hepatic Fibrosis | 7 | PM | 36155216 | 📋 | Salvianolic acid B suppresses hepatic stellate cell activation and liver fibrosis by inhibiting the NF-κB signaling pathway via miR-6499-3p/LncRNA-ROR |
| Salvianolic Acid | Hepatic Fibrosis | 6 | PM | 35991894 | 📋 | Salvianolic acid B inhibits autophagy and activation of hepatic stellate cells induced by TGF-β1 by downregulating the MAPK pathway |
| Salvianolic Acid | Hepatic Fibrosis | 4 | PM | 35057680 | 📋 | Salvianolic acid A suppresses CCl 4-induced liver fibrosis through regulating the Nrf2/HO-1, NF-κB/IκBα, p38 MAPK, and JAK1/STAT3 signaling pathways |
| Salvianolic Acid | Hepatic Fibrosis | 3 | PM | 34970339 | 📋 | Salvianolic acid B inhibits the progression of liver fibrosis in rats via modulation of the Hedgehog signaling pathway |
| Salvianolic Acid | Hepatic Fibrosis | 5 | PM | 32980439 | 📋 | Salvianolic acid B blocks hepatic stellate cell activation via FGF19/FGFR4 signaling |
| Salvianolic Acid | Hepatic Fibrosis | 2 | PM | 31678285 | 📋 | Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro |
| Salvianolic Acid | Hepatic Fibrosis | 1 | PM | 17005083 | 📋 | Study on Effects of Extracts From Salvia Miltiorrhiza and Curcuma Longa in Inhibiting Phosphorylated Extracellular Signal Regulated Kinase Expression in Rat's Hepatic Stellate Cells |
| Salvianolic Acid | Hepatotoxicity | 2 | PM | 38382651 | 📋 | Salvianolic acid extract prevents Tripterygium wilfordii polyglycosides-induced acute liver injury by modulating bile acid metabolism |
| Salvianolic Acid | Hepatotoxicity | 1 | PM | 37107244 | 📋 | Salvianolic Acid A Protects against Acetaminophen-Induced Hepatotoxicity via Regulation of the miR-485-3p/SIRT1 Pathway |
| Salvianolic Acid | Liver Cancer | 3 | PM | 36509132 | 📋 | Salvianolic acid B exerts an anti-hepatocellular carcinoma effect by regulating the Hippo/YAP pathway and promoting pSmad3L to pSmad3C simultaneously |
| Salvianolic Acid | Liver Cancer | 1 | PM | 34876128 | 📋 | Salvianolic acid B targets mortalin and inhibits the migration and invasion of hepatocellular carcinoma via the RECK/STAT3 pathway |
| Salvianolic Acid | Liver Cancer | 2 | PM | 33290806 | 📋 | Smad3 C-terminal phosphorylation site mutation attenuates the hepatoprotective effect of salvianolic acid B against hepatocarcinogenesis |
| Salvianolic Acid | Liver Damage | 1 | PM | 33732314 | 📋 | Salvianolic acid B protects against acute and chronic liver injury by inhibiting Smad2C/L phosphorylation |
| Salvianolic Acid | MAFLD | 2 | PM | 38674860 | 📋 | Supplementation of Silymarin Alone or in Combination with Salvianolic Acids B and Puerarin Regulates Gut Microbiota and Its Metabolism to Improve High-Fat Diet-Induced NAFLD in Mice |
| Salvianolic Acid | MAFLD | 1 | PM | 35932615 | 📋 | Salvianolic acid B ameliorates non-alcoholic fatty liver disease by inhibiting hepatic lipid accumulation and NLRP3 inflammasome in ob/ob mice |
| Salvianolic Acid | Non-Alcoholic Steatohepatitis | 1 | PM | 29224910 | 📋 | Regulation of SIRT3/FOXO1 Signaling Pathway in Rats with Non-alcoholic Steatohepatitis by Salvianolic Acid B |
